Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19Helena Janols, Natividad Benito, Noemí Corbacho et al.|JAMA|2021Cited by 723
Management of Immunotherapy-Related Toxicities, Version 1.2019, NCCN Clinical Practice Guidelines in OncologyJohn A. Thompson, Jillian L. Scavone, Bryan J. Schneider et al.|Journal of the National Comprehensive Cancer Network|2019Cited by 560
NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020John A. Thompson, Anita M. Engh, Bryan J. Schneider et al.|Journal of the National Comprehensive Cancer Network|2020Cited by 484
Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studiesReuben Benjamin, Jackie Chappell, Charlotte Graham et al.|The Lancet|2020Cited by 358
Identification of Chimeric Antigen Receptors That Mediate Constitutive or Inducible Proliferation of T CellsMatthew J. Frigault, Carl H. June, Ji‐Hyun Lee et al.|Cancer Immunology Research|2015Cited by 332